Davidson / Toth / Maki Therapeutic Lipidology

2007
ISBN: 978-1-59745-533-6
Verlag: Humana Press
Format: PDF
Kopierschutz: Wasserzeichen (»Systemvoraussetzungen)

E-Book, Englisch, 495 Seiten, eBook

Reihe: Contemporary Cardiology

Since the creation of the American Board of Clinical Lipidology, many clinicians have wanted an up-to-date, comprehensive reference on lipidology. Now, for the first time, clinicians can find such a reference in Therapeutic Lipidology. This volume will provide practicing clinicians with a focused and intensive but useable source of information on the identification and management of dyslipidemias. Among the topics discussed in this groundbreaking text are lipoprotein metabolism, pharmacological therapy for cardiovascular disease, thiazolidinediones on serum lipoproteins, hypertriglyceridemia, dyslipidemia and obesity, dyslipidemia in children, and much more.The pace of scientific and clinical advances in lipidology is astounding. This reference will serve as a lifelong stimulus to the reader to continue to learn about the ever changing and fascinating field of therapeutic lipidology. Comprehensive and cutting-edge, Therapeutic Lipidology will empower readers to improve and extend the lives of the patients they so conscientiously serve.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Davidson, Michael

Toth, Peter P.

Maki, Kevin C

Inhaltsverzeichnis

Lipoprotein Metabolism and Vascular Biology.- Genetic Disorders of Lipoprotein Metabolism.- International Guidelines for Dyslipidemia Management.- Pathophysiology and Management of Dyslipidemias Associated with Obesity, Type 2 Diabetes, and Other Insulin-Resistant States.- C-Reactive Protein and Other Inflammatory Markers in Cardiovascular Disease.- Dietary Prescriptions to Control Dyslipidemias and Coronary Disease Risk.- Pharmacological Therapy for Cardiovascular Disease.- Effects of Thiazolidinediones on Serum Lipoproteins.- High-Density Lipoproteins.- Management of Hypertriglyceridemia.- Lowering Low-Density Lipoprotein Cholesterol Levels to Reduce Atherosclerotic Coronary Heart Disease Risk.- Lipoprotein(a) as an Emerging Risk Factor for Atherothrombosis.- Familial Hypercholesterolemia and Lipid Apheresis.- Phytosterolemia.- Utilization of Lipoprotein Subfractions.- Cardiovascular Disease in Women.- Management of Lipids in the Elderly.- The Clinical Use of Noninvasive Modalities in the Assessment of Atherosclerosis.- Management of Dyslipidemia in Children.- The Allied Health Professional’s Role in the Management of Dyslipidemia.- Development and Management of a Lipid Clinic.- The American Board of Clinical Lipidology Physicianbreak Certification Program.